SCHEMBL1034997

SCHEMBL1034997

Cc1cc(C)c(C(=O)P(CC(=O)O)C(=O)c2c(C)cc(C)cc2C)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HPGD P15428 3/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 3/20 0.36
POLB P06746 1/20 0.36
TSHR P16473 1/20 0.36
ALDH1A1 P00352 3/20 0.35
MAPK1 P28482 1/20 0.35
TPMT P51580 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
TAS1R3 Q7RTX0 2/20 0.34
TAS1R1 Q7RTX1 2/20 0.34
TAS1R2 Q8TE23 2/20 0.34
FABP4 P15090 1/20 0.34
MCOLN3 Q8TDD5 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,6-Hexanediol SCHEMBL17819100 0.90 KDM4E (0.35) KDM4EL3MBTL1HPGDLMNAMEN1
SCHEMBL17819098 0.86 TAS1R3 (0.36) KDM4EL3MBTL1MEN1KMT2AMAPT
SCHEMBL20636994 0.81 NPSR1 (0.40) KDM4EL3MBTL1HPGDLMNAMEN1
SCHEMBL1035817 0.80 KDM4E (0.37) KDM4EL3MBTL1HPGDLMNAMEN1
SCHEMBL1037385 0.80 KMT2A (0.46) KDM4EL3MBTL1HPGDLMNAMEN1
SCHEMBL1037277 0.79 LMNA (0.37) KDM4EL3MBTL1HPGDLMNAMEN1
SCHEMBL1034451 0.79 NLRP3 (0.45) KDM4EL3MBTL1HPGDLMNAMEN1
SCHEMBL1037184 0.78 LMNA (0.38) KDM4EL3MBTL1HPGDLMNAMEN1
SCHEMBL13412090 0.76 KDM4E (0.41) KDM4EL3MBTL1HPGDLMNAMEN1
SCHEMBL21111136 0.76 KMT2A (0.39) KDM4EL3MBTL1HPGDLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023675-B2 Polymer nanoparticles ETH ZUERICH (CH) 2018-07-17 US disclosed
US-10023675-B2 Polymer nanoparticles ETH ZUERICH (CH) 2018-07-17 US disclosed
US-10023675-B2 Polymer nanoparticles ETH ZUERICH (CH) 2018-07-17 US disclosed
EP-2630163-B1 ULTRA FAST PROCESS FOR THE PREPARATION OF POLYMER NANOPARTICLES MAX PLANCK GESELLSCHAFT (DE) 2018-05-16 EP disclosed
US-20160024241-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2016-01-28 US disclosed
US-20160024241-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2016-01-28 US disclosed
US-20160024241-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2016-01-28 US disclosed
US-9181358-B2 Polymer nanoparticles ETH ZUERICH (CH) 2015-11-10 US disclosed
US-9181358-B2 Polymer nanoparticles ETH ZUERICH (CH) 2015-11-10 US disclosed
US-9181358-B2 Polymer nanoparticles ETH ZUERICH (CH) 2015-11-10 US disclosed
US-20120115963-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2012-05-10 US disclosed
US-20120115963-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2012-05-10 US disclosed
US-20120115963-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2012-05-10 US disclosed
WO-2012052148-A1 ULTRA FAST PROCESS FOR THE PREPARATION OF POLYMER NANOPARTICLES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2012-04-26 WO disclosed
EP-1814891-B1 BISACYLPHOSPHANES AND THEIR USE AS PHOTOINITIATORS; PROCESS FOR PREPARING ACYLPHOSPHANES BASF SE (DE) 2011-01-26 EP disclosed
WO-2010121387-A1 POLYMER NANOPARTICLES ETH Zürich (CH) 2010-10-28 WO disclosed
US-7687657-B2 Process for preparing acylphosphanes and derivatives thereof CIBA SPECIALITY CHEMICALS CORPORATION (US) 2010-03-30 US disclosed
US-20080004464-A1 Process for Preparing Acylphosphanes and Derivatives Thereof IGM GROUP B.V. (NL) 2008-01-03 US disclosed
EP-1814891-A1 PROCESS FOR PREPARING ACYLPHOSPHANES AND DERIVATIVES THEREOF Ciba Specialty Chemicals Holding Inc. (CH) 2007-08-08 EP disclosed
WO-2006056541-A1 PROCESS FOR PREPARING ACYLPHOSPHANES AND DERIVATIVES THEREOF CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004464-A1 Process for Preparing Acylphosphanes and Derivatives Thereof ME2, ME3, MEP1A KDM4E 2950/4885L3MBTL1 1140/4885HPGD 1061/4885
US-20160024241-A1 POLYMER NANOPARTICLES POLQ, POLN, POLA1 KDM4E 4562/4885L3MBTL1 3134/4885HPGD 908/4885
US-10023675-B2 Polymer nanoparticles POLQ, POLN, POLA1 KDM4E 4562/4885L3MBTL1 3134/4885HPGD 908/4885
US-20120115963-A1 POLYMER NANOPARTICLES POLQ, POLN, POLA1 KDM4E 4562/4885L3MBTL1 3134/4885HPGD 908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.